Carhart-Harris R L, Kaelen M, Bolstridge M, Williams T M, Williams L T, Underwood R, Feilding A, Nutt D J
Imperial College London,Centre for Neuropsychopharmacology,Division of Brain Sciences,Faculty of Medicine,London,UK.
Department of Psychiatry,The University of Bristol,Bristol,UK.
Psychol Med. 2016 May;46(7):1379-90. doi: 10.1017/S0033291715002901. Epub 2016 Feb 5.
Lysergic acid diethylamide (LSD) is a potent serotonergic hallucinogen or psychedelic that modulates consciousness in a marked and novel way. This study sought to examine the acute and mid-term psychological effects of LSD in a controlled study.
A total of 20 healthy volunteers participated in this within-subjects study. Participants received LSD (75 µg, intravenously) on one occasion and placebo (saline, intravenously) on another, in a balanced order, with at least 2 weeks separating sessions. Acute subjective effects were measured using the Altered States of Consciousness questionnaire and the Psychotomimetic States Inventory (PSI). A measure of optimism (the Revised Life Orientation Test), the Revised NEO Personality Inventory, and the Peter's Delusions Inventory were issued at baseline and 2 weeks after each session.
LSD produced robust psychological effects; including heightened mood but also high scores on the PSI, an index of psychosis-like symptoms. Increased optimism and trait openness were observed 2 weeks after LSD (and not placebo) and there were no changes in delusional thinking.
The present findings reinforce the view that psychedelics elicit psychosis-like symptoms acutely yet improve psychological wellbeing in the mid to long term. It is proposed that acute alterations in mood are secondary to a more fundamental modulation in the quality of cognition, and that increased cognitive flexibility subsequent to serotonin 2A receptor (5-HT2AR) stimulation promotes emotional lability during intoxication and leaves a residue of 'loosened cognition' in the mid to long term that is conducive to improved psychological wellbeing.
麦角酸二乙酰胺(LSD)是一种强效的血清素能致幻剂或迷幻剂,能以显著且新颖的方式调节意识。本研究旨在通过一项对照研究来检验LSD的急性和中期心理效应。
共有20名健康志愿者参与了这项自身对照研究。参与者在两个不同时间分别接受一次LSD(75微克,静脉注射)和一次安慰剂(生理盐水,静脉注射),顺序均衡,两次给药间隔至少2周。使用意识状态改变问卷和拟精神病状态量表(PSI)来测量急性主观效应。在基线以及每次给药后2周发放一份乐观主义量表(修订后的生活取向测试)、修订后的大五人格量表和彼得妄想量表。
LSD产生了强烈的心理效应;包括情绪高涨,但在PSI(一种类似精神病症状的指标)上得分也很高。在服用LSD(而非安慰剂)2周后观察到乐观主义和开放性人格特质增加,且妄想思维没有变化。
目前的研究结果强化了这样一种观点,即迷幻剂会急性引发类似精神病的症状,但在中长期会改善心理健康。有人提出,情绪的急性改变是认知质量更基本调节的次要结果,并且血清素2A受体(5-HT2AR)刺激后认知灵活性的增加会在中毒期间促进情绪不稳定,并在中长期留下“认知松弛”的痕迹,这有利于改善心理健康。